Wockhardt President Manufacturing Quality and R&D Dr Sharma resigns

Management Changes View source PDF Explain this filing

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.0%Reaction day

₹1349.00

prior close

₹1353.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.8%+3.2% vs market

Pharmaceuticals peers, median of 155sector+0.2%+3.8% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Smallcap 250 and 3.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

+0.1

15m

+0.6

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.0+0.8+3.2+0.2+3.8

Next day

+3.5-0.3+3.7-0.4+3.8

+3.1-0.6+3.7-1.1+4.2

+3.9+1.9+2.0+0.7+3.3

+5.7+2.4+3.3+1.3+4.4

+3.9+2.6+1.3+1.4+2.5

+3.1+0.2+3.0+0.3+2.9

15d

+2.8+0.5+2.4-2.6+5.4

-4.7-4.5-0.2-5.1+0.4

-5.5-6.8+1.3-7.9+2.5

+6.1+5.8+0.2+0.7+5.4

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Sanjeev Kumar Sharma, President of Manufacturing, Quality and R&D at Wockhardt Limited, has resigned from his role as Senior Management Personnel effective close of business on 2 February 2026. The company stated the reason as personal. The intimation has been filed with BSE and NSE under SEBI Listing Regulations.

Likely market impact

Senior-level exit in key operational areas may create short-term uncertainty around manufacturing and R&D continuity at the pharma company.